Use of cardiac magnetic resonance and echocardiography in population-based studies: why, where, and when?
590 - 596
Circ Cardiovasc Imaging
MetadataShow full item record
Population research studies are often directed towards eliciting the association of physiologic measurements (eg. LV function) and clinical variables (eg hypertension) with outcomes (1). Although cardiac magnetic resonance (CMR) is known to be accurate and versatile, until recently, the diffusion of CMR technology was too limited by technical and logistic challenges to consider its use in population studies on a mass scale (>10,000). However, with recent technical developments, CMR has reached a level of maturity and ease of use that makes its use in large-scale population studies a practical reality for the first time. The goal of this review is to facilitate the process of selecting imaging methods for population research studies based on design requirements and existing experience with the techniques.
AuthorsMarwick, TH; Neubauer, S; Petersen, SE
- Cardiovascular 
Showing items related by title, author, creator and subject.
Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study. Malcolme-Lawes, LC; Juli, C; Karim, R; Bai, W; Quest, R; Lim, PB; Jamil-Copley, S; Kojodjojo, P; Ariff, B; Davies, DW;... (2013-08)BACKGROUND: For late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) assessment of atrial scar to guide management and targeting of ablation in atrial fibrillation (AF), an objective, reproducible ...
WS02a: Making the Human Body Transparent: The Impact of Nuclear Magnetic Resonance and Magnetic Resonance Imaging (02-Jul-1996) History of Twentieth Century Medicine Group; History of Modern Biomedicine Research Group (2017-05-18)Selection of photos taken at the Witness Seminar “Making the Body More Transparent: The Impact of Nuclear Magnetic Resonance and Magnetic Resonance Imaging” held by the History of Twentieth Century Medicine Group, 02-Jul-1996. ...
Hye, A; Riddoch-Contreras, J; Baird, AL; Ashton, NJ; Bazenet, C; Leung, R; Westman, E; Simmons, A; Dobson, R; Sattlecker, M;... (2014-11)BACKGROUND: The study aimed to validate previously discovered plasma biomarkers associated with AD, using a design based on imaging measures as surrogate for disease severity and assess their prognostic value in predicting ...